evetiracetam for Treatment of Non-psychotic and Non-depressive behavioural symptoms of dementia.

Dep geriatrics JBZHervensebaan 4Postbus 1101 5200 BD Den Bosch073-69986290 sites25 target enrollmentTBD

Conditions3 moths, prospective, open label trial

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: 3 moths, prospective, open label trial
Sponsor: Dep geriatrics JBZHervensebaan 4Postbus 1101 5200 BD Den Bosch073-6998629
Enrollment: 25
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Dautzenberg PLJ et al. Medicamenteuze behaneling van gedrags- en psychische problemen bij dementie (BPSD). Tijdschrift voor verpleeghuisgeneeskunde 2003;27(5):5-9. Weiner MF et al. Levetiracetam for agitated Alzheimer's disease patients. Int J Psychogeriatrics 2005;17(2):327-8.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

Dep geriatrics JBZHervensebaan 4Postbus 1101 5200 BD Den Bosch073-6998629

Eligibility Criteria

Inclusion Criteria

•1\. Ambulant patients with dementia, level Reisberg 4\-6;
•2\. Informant available.;

Exclusion Criteria

•1\. NPI item hallucinations, delusions and depression \> ;1
•2\. Epilepsia;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Not Applicable

evetiracetam for Treatment of Non-psychotic and Non-depressive behavioural symptoms of dementiaDementiaMental and Behavioural DisordersMental disorders

ISRCTN97133543Jeroen Bosch Hospital (The Netherlands)25

Terminated

Not Applicable

Non Pharmacological Management of Behavioural Symptoms in Nursing HomeALZHEIMER Disease

NCT00824967Centre Hospitalier Universitaire de Nice306

Active, not recruiting

Phase 1

An investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a proof of concept studyAlzheimer's diseaseMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

EUCTR2016-003109-32-GBniversity of Oxford30

Terminated

Not Applicable

Evaluating the Impact of VR-therapy on BPSD and QoL of Individuals With Dementia Admitted to HospitalDementiaDelirium Superimposed on Dementia

NCT03941119University Health Network, Toronto77

Not yet recruiting

Phase 2

Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)Alzheimer Disease

NCT04004702Walter Reed National Military Medical Center65